2015
DOI: 10.1590/s0102-865020150030000006
|View full text |Cite
|
Sign up to set email alerts
|

Preconditioning with L-alanyl-glutamine upon cerebral edema and hypocampus red neurons counting in rats subjected to brain ischemia /reperfusion injury

Abstract: Conception, design, intellectual and scientific content of the study, critical revision, final approval. ABSTRACT PURPOSE:To evaluate the effects of the dipeptide L-alanyl-glutamine (L-Ala-Gln) as a preconditioning agent to potentially promote reduction in the intensity of lesion or induction of resilience in rats subjected to global cerebral ischemia/reperfusion (I/R) injury. METHODS:Thirty-six male Wistar rats weighing 280-300g were randomly assigned to six groups (n=6). Groups Sham 1h and 24hwere treated wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Ala-Gln supplementation was found to reduce the release of inflammatory factors, attenuate the inflammatory response, increase proliferation, and prevent apoptosis and oxidative injury under different physiological conditions in a similar manner to that of glutamine (Haynes et al, 2009;Cunha Filho et al, 2011;Ueno et al, 2011;Nosworthy et al, 2016). Several studies have showed the protective effects of Ala-Gln against the injury induced by myocardial, intestinal, hepatic or cerebral ischemia reperfusion (Tazuke et al, 2003;Araujo Junior et al, 2011;Vasconcelos et al, 2015;Liu et al, 2018). In addition, Ala-Gln is usually used in enteral nutrition.…”
Section: Introductionmentioning
confidence: 99%
“…Ala-Gln supplementation was found to reduce the release of inflammatory factors, attenuate the inflammatory response, increase proliferation, and prevent apoptosis and oxidative injury under different physiological conditions in a similar manner to that of glutamine (Haynes et al, 2009;Cunha Filho et al, 2011;Ueno et al, 2011;Nosworthy et al, 2016). Several studies have showed the protective effects of Ala-Gln against the injury induced by myocardial, intestinal, hepatic or cerebral ischemia reperfusion (Tazuke et al, 2003;Araujo Junior et al, 2011;Vasconcelos et al, 2015;Liu et al, 2018). In addition, Ala-Gln is usually used in enteral nutrition.…”
Section: Introductionmentioning
confidence: 99%
“…Several studies have shown that glutamine reduces IR damage in many tissues and organs, but there are a limited number of studies that have shown its effects on IR injury in brain tissue. [20] In the current study, we used Wistar albino rats as the experimental animal model, as small rodents, particularly rats, are preferred in constructing the cerebral ischemia model due to their similarity to human cerebral physiology and vascularization. The rodents' small brain masses also provide good fixation in procedures, such as paraffin embedding and frozen sectioning.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have shown that glutamine reduces IR damage in many tissues and organs, but there are a limited number of studies that have shown its effects on IR injury in brain tissue. [ 20 ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation